Financial News
Articles published by Sangamo Therapeutics, Inc.
![](https://mms.businesswire.com/media/20250206513390/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20241230895593/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20241218204650/en/2336056/5/AST_FullColor_Horizontal_Transparent.jpg)
![](https://mms.businesswire.com/media/20241119527555/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20241112955936/en/736004/5/Sangamo_logoTM.jpg)
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
November 12, 2024
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20241104090881/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20241022733270/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240806551275/en/736004/5/Sangamo_logoTM.jpg)
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
August 06, 2024
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240806084723/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240730067228/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240724053258/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240509815876/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240509715519/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240502412698/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240422796174/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240322341913/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240313945090/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240313380216/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240312863070/en/736004/5/Sangamo_logoTM.jpg)
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast
March 12, 2024
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20240212042496/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20240205333085/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20231101893355/en/736004/5/Sangamo_logoTM.jpg)
Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results
November 01, 2023
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20231025916590/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20231023250843/en/736004/5/Sangamo_logoTM.jpg)
![](https://mms.businesswire.com/media/20230920374990/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20230808479265/en/736004/5/Sangamo_logoTM.jpg)
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
August 08, 2023
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20230801222221/en/736004/5/Sangamo_logoTM.jpg)
Via Business Wire
Tickers
SGMO
![](https://mms.businesswire.com/media/20230719123616/en/1844387/22/Chroma_Logo.jpg)
![](https://mms.businesswire.com/media/20230717830975/en/736004/5/Sangamo_logoTM.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.